1)皆川倫範,西澤秀治,上垣内崇行,他:NMP22迅速定性法(BladderチェックNMP22)による尿路上皮腫瘍診断.日泌尿会誌 97:20-26,2006
2)吉川慎一,山本 豊,細田 悟,他:膀胱癌検出における尿中NMP22(Nuclear Matrix Protein 22)Bladder Chekの臨床的有用性の検討.泌尿紀要 52:167-172,2006
3)Yang CH, Lambie EJ and Snyder M:NuMA:an unusually long and coiled-coil related protein in the mammalian nucleus. J cell Biol 116:1303-1317, 1992
4)Atsu N, Ekici S, Oge O, et al:False-positive results of the NMP22 test due to hematuria. J Urol 167:555-558, 2002
5)丸茂 健,村井 勝:無症候性顕微鏡的血尿に対する2次スクリーニングの意義.臨泌 53:39-43,1999
6)Mariani AJ, Mariani MC, Macchioni C, et al:The significance of adult hematuria:1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol 141:350-355, 1989
7)Grossman HB, Messing E, Soloway M, et al:Detection of bladder cancer using a point-of-care proteomic assay. JAMA 293:810-816, 2005
8)横山 貴,関川瑠美,林 哲男,他:尿路上皮癌における迅速定性法BladderチェックNMP22の有用性.臨床病理 52:199-203,2004
9)Nabi G, Greene DR and O'Donnell M:How important is urinary cytology in the diagnosis of urological malignancies? Eur Urol 43:632-636, 2003
10)Tomera KM:NMP22 BladderChek Test:point-of-care technology with life-and money-saving potential. Expert Rev Mol Diagn 4:783-794, 2004
11)小林 裕,池田 仁,平塚裕一郎,他:膀胱癌における尿中NMP22(Nuclear matrix protein)Bladder Chekの臨床的有用性―NMP22 ELISAとの比較検討.西日本泌尿器科 66:690-695,2004